Analysis of BRAF mutation status in high-risk malignant melanoma patients having received HD IFNa therapy in adjuvant setting

被引：0

作者：

Hlavata, Zuzana

Salek, Tomas

Andrezalova, Iveta

Dolinsky, Jozef

Svabova, Veronika

Porsok, Stefan

Berkovcova, Jitka

Waczulikova, Iveta

机构：

[1] Natl Canc Inst, Dept Clin Oncol, Bratislava, Slovakia

[2] Natl Canc Inst, Bratislava, Slovakia

[3] Masaryk Mem Canc Inst, Brno, Czech Republic

[4] Comenius Univ, Div Biomed Phys, Fac Math Phys & Informat, Bratislava, Slovakia

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e19020

引用

页数：1